Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven D Pearson

Showing results (121-130 of 169) with videos related to

Pageof 17
Sort By:
Journal of Managed Care & Specialty Pharmacy|March 26, 2021
Cost-effectiveness of oral semaglutide added to current antihyperglycemic treatment for type 2 diabetesGregory F Guzauskas, David M Rind, Katherine Fazioli, et al.
Journal of Managed Care & Specialty Pharmacy|December 28, 2018
The Effectiveness and Value of Patisiran and Inotersen for Hereditary Transthyretin AmyloidosisKristin Mickle, Karen E Lasser, Jeffrey S Hoch, et al.
Journal of Managed Care & Specialty Pharmacy|October 27, 2023
Gene therapies for sickle cell disease: Effectiveness and valueDmitriy Nikitin, Francesca L Beaudoin, Praveen Thokala, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 28, 2016
Evaluating the Importance of Heterogeneity of Treatment Effect: Variation in Patient Utilities Can Influence Choice of the "Optimal" Oral Anticoagulant for Atrial FibrillationChristopher G Cameron, Patricia G Synnott, Steven D Pearson, et al.
AJR. American Journal of Roentgenology|March 24, 2011
A simulation model of clinical and economic outcomes of cardiac CT triage of patients with acute chest pain in the emergency departmentAlexander Goehler, Daniel A Ollendorf, Marie Jaeger, et al.
Journal of Managed Care & Specialty Pharmacy|February 24, 2022
Mavacamten for hypertrophic cardiomyopathy: effectiveness and valueMolly Beinfeld, Jason H Wasfy, Surrey Walton, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 2, 2024
Informing the United States Medicare Drug Price Negotiation for Apixaban and Rivaroxaban: Methodological Considerations for Value Assessments Many Years After LaunchMarina Richardson, Abigail C Wright, Jeffrey A Tice, et al.
Journal of Comparative Effectiveness Research|April 1, 2015
Translating comparative effectiveness research into Medicaid payment policy: views from medical and pharmacy directorsJoel S Weissman, Kimberly Westrich, J Lee Hargraves, et al.
The American Journal of Managed Care|May 10, 2007
The response of physician groups to P4P incentivesAteev Mehrotra, Steven D Pearson, Kathryn L Coltin, et al.
Journal of Managed Care & Specialty Pharmacy|August 23, 2023
The effectiveness and value of lecanemab for early Alzheimer disease: A summary from the Institute for Clinical and Economic Review's California Technology Assessment ForumAbigail C Wright, Grace A Lin, Melanie D Whittington, et al.
Pageof 17

Showing results (121-130 of 169) with videos related to

Sort By:
Pageof 17
Journal of Managed Care & Specialty Pharmacy|March 26, 2021
Cost-effectiveness of oral semaglutide added to current antihyperglycemic treatment for type 2 diabetesGregory F Guzauskas, David M Rind, Katherine Fazioli, et al.
Journal of Managed Care & Specialty Pharmacy|December 28, 2018
The Effectiveness and Value of Patisiran and Inotersen for Hereditary Transthyretin AmyloidosisKristin Mickle, Karen E Lasser, Jeffrey S Hoch, et al.
Journal of Managed Care & Specialty Pharmacy|October 27, 2023
Gene therapies for sickle cell disease: Effectiveness and valueDmitriy Nikitin, Francesca L Beaudoin, Praveen Thokala, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 28, 2016
Evaluating the Importance of Heterogeneity of Treatment Effect: Variation in Patient Utilities Can Influence Choice of the "Optimal" Oral Anticoagulant for Atrial FibrillationChristopher G Cameron, Patricia G Synnott, Steven D Pearson, et al.
AJR. American Journal of Roentgenology|March 24, 2011
A simulation model of clinical and economic outcomes of cardiac CT triage of patients with acute chest pain in the emergency departmentAlexander Goehler, Daniel A Ollendorf, Marie Jaeger, et al.
Journal of Managed Care & Specialty Pharmacy|February 24, 2022
Mavacamten for hypertrophic cardiomyopathy: effectiveness and valueMolly Beinfeld, Jason H Wasfy, Surrey Walton, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 2, 2024
Informing the United States Medicare Drug Price Negotiation for Apixaban and Rivaroxaban: Methodological Considerations for Value Assessments Many Years After LaunchMarina Richardson, Abigail C Wright, Jeffrey A Tice, et al.
Journal of Comparative Effectiveness Research|April 1, 2015
Translating comparative effectiveness research into Medicaid payment policy: views from medical and pharmacy directorsJoel S Weissman, Kimberly Westrich, J Lee Hargraves, et al.
The American Journal of Managed Care|May 10, 2007
The response of physician groups to P4P incentivesAteev Mehrotra, Steven D Pearson, Kathryn L Coltin, et al.
Journal of Managed Care & Specialty Pharmacy|August 23, 2023
The effectiveness and value of lecanemab for early Alzheimer disease: A summary from the Institute for Clinical and Economic Review's California Technology Assessment ForumAbigail C Wright, Grace A Lin, Melanie D Whittington, et al.
Pageof 17